Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Probiotic Use May Reduce Antibiotic Prescriptions

By Georgetown University | September 17, 2018

Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Their study, supported in part by the International Scientific Association for Probiotics and Prebiotics and published in the European Journal of Public Health, found that when the results from 12 studies were pooled together, infants and children were 29 percent less likely to have been prescribed antibiotics if they received probiotics as a daily health supplement. When the analysis was repeated with only the highest quality studies, this percentage increased to 53 percent.

The findings are very intriguing, the researchers say. “Given this finding, potentially one way to reduce the use of antibiotics is to use probiotics on a regular basis,” says the study’s senior investigator, Daniel Merenstein, MD, a professor in the Department of Family Medicine at Georgetown University School of Medicine. He is also director of research programs in the department.

According to the Centers for Disease Control and Prevention (CDC), there are about 2 million cases of antibiotic resistant infections yearly in the U.S., resulting in 23,000 deaths. Reducing the use of antibiotics is one strategy in combating resistance.

“We already have evidence that consuming probiotics reduces the incidence, duration, and severity of certain types of common acute respiratory and gastrointestinal infections,” Merenstein says. “The question is whether that reduction is solidly linked to declining use of antibiotics, and we see that there is an association.”

“More studies are needed in all ages, and particularly in the elderly, to see if sustained probiotic use is connected to an overall reduction in antibiotic prescriptions. If so, this could potentially have a huge impact on the use of probiotics in general medicine and consumers in general,” says the study’s lead author Sarah King, from Cambridge, UK.

How probiotics help fight infections, especially those in the respiratory tract and lower digestive tract, is not clear. However, Merenstein says, “There are many potential mechanisms, such as probiotic production of pathogen inhibitors, immune regulation, among others.

“We don’t know all the mechanisms probiotic strains may leverage. But since most of the human immune system is found in the gastrointestinal tract, ingesting healthy bacteria may competitively exclude bacterial pathogens linked to gut infections and may prime the immune system to fight others,” he says.

The probiotics used in the reviewed studies were strains of Lactobacillus and Bifidobacterium.

In addition to King and Merenstein, authors include Daniel Tancredi, from the University of California, Davis; Irene Lenoir-Wijnkoop, University of Utrecht, Netherlands; Kelsie Gould, Hailey Vann and Grant Connors, MLS, from Georgetown University; Mary Ellen Sanders, International Scientific Association for Probiotics and Prebiotics; Jeffrey A. Linder, MD, MPH, Northwestern University Feinberg School of Medicine; and Andi L. Shane, MD, MPH, Emory University School of Medicine.

SOURCE: Georgetown University


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE